MGMT-UNMETHYLATED GLIOBLASTOMA

Clinical trials for MGMT-UNMETHYLATED GLIOBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new MGMT-UNMETHYLATED GLIOBLASTOMA trials appear

Sign up with your email to follow new studies for MGMT-UNMETHYLATED GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

Scientists test new pill to fight deadly brain tumors

Disease control Terminated

This early-stage study tested a new oral drug called navtemadlin (AMG 232) for glioblastoma, a fast-growing brain cancer. The trial had two parts: first, to see if the drug could reach brain tumor tissue in patients whose cancer had returned; second, to find a safe dose to combin…

Matched conditions: MGMT-UNMETHYLATED GLIOBLASTOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

MGMT-UNMETHYLATED GLIOBLASTOMA

Get alerted when new MGMT-UNMETHYLATED GLIOBLASTOMA trials appear

Scientists test new pill to fight deadly brain tumors